
1. semin liver dis. 2014 feb;34(1):89-97. doi: 10.1055/s-0034-1371082. epub 2014 apr
29.

hepatitis c, global issue: access care new therapeutic preventive
approaches resource-constrained areas.

lemoine m(1), thursz m(1).

author information: 
(1)hepatology & gastroenterology section, imperial college, london, united
kingdom.

with advent oral direct-acting antiviral drugs broad range of
genotypic activity low incidence side effects, entering an
exciting new era therapeutics hepatitis c virus (hcv). however, is
not yet clear benefit innovations: advantages be
limited hcv patients industrialized nations could whole community of
hcv-infected individuals given access treatment? majority people 
infected hcv live resource-limited settings important overcome
the barriers restrict access treatment areas. drug costs, public
and professional education, simplified diagnostics, political imperative 
need addressed majority hcv-infected individuals benefit 
from new generation hcv antivirals.

thieme medical publishers 333 seventh avenue, new york, ny 10001, usa.

doi: 10.1055/s-0034-1371082 
pmid: 24782262  [indexed medline]

